Pfizer (NY:PFE)

NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) Looks to Supercharge Reach, Impact of GLP-1 Agonists with Proprietary Drug-Delivery Solution

Topics Economy

January 12, 2024

Topics Intellectual Property

DGE’s 3rd Real World Evidence & Market Access

January 11, 2024

Swixx BioPharma Consolidates QMS, RIM, and Safety Processes Digital with the CARA Life Sciences Platform

Topics Artificial Intelligence

January 11, 2024

LONDON - Jan. 11, 2024 - PRLog -- Generis, creator of the cloud data, content, and business process management platform CARA™, announces that Swixx BioPharma has selected the CARA Life Sciences...

Via PRLog

Generis and Userlane Forge Strategic Partnership to Accelerate Digital Transformation in Regulated Industries

December 19, 2023

LONDON - Dec. 19, 2023 - PRLog -- Generis and Userlane today announced a strategic partnership. Generis is the developer of the CARA platform for data, content, and business process management in...

Via PRLog

Pfizer Inc. (NYSE: PFE) is One of Friday Morning’s Most Active Stocks

December 15, 2023

Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Wednesday Trading

December 13, 2023

AstraZeneca's stock rose 8.95% in the past month on a bullish outlook, driven by growing sales of cancer and diabetes drugs and a strategic acquisition

AstraZeneca: Rebound in 2024 with double-digit earnings growth

January 11, 2024

Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Investment Corporation

January 10, 2024

From Pfizer Inc.

TIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted for Priority Review by U.S. Food and Drug Administration for Patients with Recurrent or Metastatic Cervical Cancer

January 09, 2024

From Genmab A/S

Generis and Ideagen Announce Integration to Advance Information Management Processes in Regulated Industries

December 13, 2023

LONDON - Dec. 13, 2023 - PRLog -- Generis, developer of the CARA Platform for data, content, and business process management, and Ideagen PleaseReview today announced their integration partnership to...

Via PRLog

TIVDAK® Supplemental Biologics License Application Accepted for Priority Review by FDA for Patients with Recurrent or Metastatic Cervical Cancer

January 09, 2024

From Pfizer Inc.

European Commission Approves Pfizer’s TALZENNA® in Combination with XTANDI® for Adult Patients with Metastatic Castration-Resistant Prostate Cancer

January 08, 2024

From Pfizer Inc.

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs

January 08, 2024

EQNX::TICKER_START (NASDAQ:LEXX),(NYSE:PFE),(NYSE:MRK),(NASDAQ:AZN),(NYSE:NVO) EQNX::TICKER_END

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs

January 08, 2024

Via FinancialNewsMedia

2 low-priced gene therapy stocks to speculate on

January 08, 2024

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe

The January Effect refers to January’s market return as predictive of the full year. But is January's performance truly an indicator of how the year may go?

Is the January Effect reliable indicator for yearly performance?

January 04, 2024

Topics ETFs

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

January 02, 2024

From Pfizer Inc.

Jobs are flowing to the healthcare space, and investment dollars are finding a home in stocks like Align Technology, even the CEO thought it to be the best

Align Technology: Protected by more factors than any other stock

December 26, 2023

Pfizer's tumultuous 2023 included a 41.84% stock plunge as revenue from Covid drugs fell. Disappointing 2024 guidance resulted in analysts slashing targets.

Pfizer's chaotic year wraps up with plunging stock, grim guidance

December 21, 2023

Pfizer Invites Public to View and Listen to Webcast of January 30 Conference Call with Analysts

December 19, 2023

From Pfizer Inc.

PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer

December 15, 2023

From Pfizer Inc.

Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings

December 15, 2023

Houston, Texas--(Newsfile Corp. - December 15, 2023) - On December 5, 2023, Cannabis Bioscience International Holdings (OTC Pink: CBIH) ,...

Via Newsfile

Topics Cannabis

Quick list of bargain stocks to end the year

December 15, 2023

Stocks are soaring after a FED dovish pivot, making these value stocks all the more attractive today. Analysts have built up cases as to why they will rally

Pfizer Declares First-Quarter 2024 Dividend

December 14, 2023

From Pfizer Inc.

Frontier IP Group PLC (AIM:FIPP, OTC:FGPPF) portfolio company The Vaccine Group (TVG) CEO Jeremy Salt speaks to Proactive after announcing that TVG has established an advisory board comprised of what...

The Vaccine Group appoints advisory board in partnering push

December 14, 2023

Via TheNewswire.com

Topics Retirement

Pfizer Completes Acquisition of Seagen

December 14, 2023

From Pfizer Inc.

The runaway success of weight-loss drugs like Novo Nordisk A/S (NYSE: NVO) Ozempic and Eli Lilly and Co. (NYSE: LLY) Mounjaro has kicked off a gold

Can Altimmune's weight-loss drug be a game-changer?

December 14, 2023

Pfizer Provides Full-Year 2024 Guidance

December 13, 2023

From Pfizer Inc.

Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

December 12, 2023

From Pfizer Inc.